Published in J Immunol on February 29, 2012
Herpes keratitis. Prog Retin Eye Res (2012) 1.55
Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus. Am J Pathol (2012) 1.19
Pathogenesis of herpes stromal keratitis--a focus on corneal neovascularization. Prog Retin Eye Res (2012) 1.05
Reversible nerve damage and corneal pathology in murine herpes simplex stromal keratitis. J Virol (2014) 1.01
Strategies for local gene therapy of corneal allograft rejection. Middle East Afr J Ophthalmol (2013) 0.94
CXCL1 but not IL-6 is required for recurrent herpetic stromal keratitis. J Immunol (2014) 0.88
Galectin-1-mediated suppression of Pseudomonas aeruginosa-induced corneal immunopathology. J Immunol (2013) 0.85
Corneal lymphangiogenesis in herpetic stromal keratitis. Surv Ophthalmol (2014) 0.81
Protective effects of SIRT1 in patients with proliferative diabetic retinopathy via the inhibition of IL-17 expression. Exp Ther Med (2015) 0.80
Type I interferon and lymphangiogenesis in the HSV-1 infected cornea - are they beneficial to the host? Prog Retin Eye Res (2013) 0.78
Herpesvirus Entry Mediator on Radiation-Resistant Cell Lineages Promotes Ocular Herpes Simplex Virus 1 Pathogenesis in an Entry-Independent Manner. MBio (2015) 0.77
IL-17A-mediated protection against Acanthamoeba keratitis. J Immunol (2014) 0.76
Potential function of miRNAs in herpetic stromal keratitis. Invest Ophthalmol Vis Sci (2013) 0.76
Controlling herpetic stromal keratitis by modulating lymphotoxin-alpha-mediated inflammatory pathways. Microbes Infect (2013) 0.76
Interleukin-17A neutralization alleviated ocular neovascularization by promoting M2 and mitigating M1 macrophage polarization. Immunology (2016) 0.76
Anti-IL-17 therapy restricts and reverses late-term corneal allorejection. J Immunol (2015) 0.75
Immunological aspects of acute and recurrent herpes simplex keratitis. J Immunol Res (2014) 0.75
Association between aqueous humor and vitreous fluid levels of Th17 cell-related cytokines in patients with proliferative diabetic retinopathy. PLoS One (2017) 0.75
Role of corneal collagen fibrils in corneal disorders and related pathological conditions. Int J Ophthalmol (2017) 0.75
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature (2006) 46.36
The biology of VEGF and its receptors. Nat Med (2003) 32.13
TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity (2006) 29.29
IL-17 and Th17 Cells. Annu Rev Immunol (2009) 23.02
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med (1996) 8.59
Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity (2009) 8.20
VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci U S A (2002) 8.10
Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity (1995) 5.96
IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol (2006) 5.27
IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med (2009) 5.05
Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci U S A (1993) 5.02
Interleukin-17 promotes angiogenesis and tumor growth. Blood (2002) 4.90
Corneal avascularity is due to soluble VEGF receptor-1. Nature (2006) 4.77
Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol (2005) 4.03
Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest (1999) 3.35
IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest (2009) 3.30
Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med (2000) 3.14
IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol (2005) 3.02
CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets. Nat Immunol (2009) 3.00
VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol (2007) 2.74
Protumor vs antitumor functions of IL-17. J Immunol (2009) 2.38
Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine (2008) 2.19
Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J Virol (1996) 2.14
Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2006) 2.12
IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J Immunol (1992) 1.90
Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol Today (1997) 1.83
Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc Natl Acad Sci U S A (2006) 1.82
VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier. J Cell Physiol (2003) 1.71
VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. J Exp Med (2009) 1.70
Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. Am J Pathol (2004) 1.70
Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids. Lab Invest (2000) 1.66
Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J Virol (2001) 1.64
Topical modulation of interleukin-1 activity in corneal neovascularization. Cornea (1998) 1.62
Early events in HSV keratitis--setting the stage for a blinding disease. Microbes Infect (2005) 1.59
DNA containing CpG motifs induces angiogenesis. Proc Natl Acad Sci U S A (2002) 1.55
Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal immunopathology. J Immunol (2011) 1.53
Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J Clin Invest (2002) 1.47
Linkage of IL-6 with neutrophil chemoattractant expression in virus-induced ocular inflammation. Invest Ophthalmol Vis Sci (2002) 1.34
Phenotypic and functional studies on ocular T cells during herpetic infections of the eye. J Immunol (1992) 1.32
Chemokine synthesis in the HSV-1-infected cornea and its suppression by interleukin-10. J Leukoc Biol (1998) 1.30
Interleukin-17 augments tumor necrosis factor-alpha-induced elaboration of proangiogenic factors from fibroblasts. Immunol Lett (2004) 1.30
IL-17 receptor signaling influences virus-induced corneal inflammation. J Leukoc Biol (2007) 1.29
Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp Eye Res (2005) 1.26
Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis. J Virol (2007) 1.24
Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts. Osteoarthritis Cartilage (2005) 1.22
IL-17 expression in human herpetic stromal keratitis: modulatory effects on chemokine production by corneal fibroblasts. J Immunol (2002) 1.19
Cytokine expression in vivo during murine herpetic stromal keratitis. Effect of protective antibody therapy. J Immunol (1993) 1.17
Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor. J Immunol (2011) 1.07
Herpes simplex virus replication-induced expression of chemokines and proinflammatory cytokines in the eye: implications in herpetic stromal keratitis. J Interferon Cytokine Res (1998) 1.06
IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes. Clin Rheumatol (2005) 1.03
MK/T-1, an immortalized fibroblast cell line derived using cultures of mouse corneal stroma. Mol Vis (2001) 0.99
Interleukin-17 regulates chemokine and gelatinase B expression in fibroblasts to recruit both neutrophils and monocytes. Immunobiology (2009) 0.96
Enhanced viral immunoinflammatory lesions in mice lacking IL-23 responses. Microbes Infect (2007) 0.96
Immunohistological study of infiltrated cells and cytokines in murine herpetic keratitis. Acta Ophthalmol Scand (2001) 0.84
Natural regulatory T cells in infectious disease. Nat Immunol (2005) 6.49
Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol (2006) 6.00
CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exp Med (2003) 4.56
CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol (2004) 3.06
Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. Am J Pathol (2004) 1.70
Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators. J Immunol (2009) 1.66
Differentiation of memory B and T cells. Curr Opin Immunol (2006) 1.59
Early events in HSV keratitis--setting the stage for a blinding disease. Microbes Infect (2005) 1.59
DNA containing CpG motifs induces angiogenesis. Proc Natl Acad Sci U S A (2002) 1.55
Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal immunopathology. J Immunol (2011) 1.53
In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses. J Virol (2006) 1.53
Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. PLoS Pathog (2010) 1.52
Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J Clin Invest (2002) 1.47
Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1. J Immunol (2010) 1.38
Herpes keratitis in the absence of anterograde transport of virus from sensory ganglia to the cornea. Proc Natl Acad Sci U S A (2005) 1.38
CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1. J Virol (2004) 1.34
Role of regulatory T cells during virus infection. Immunol Rev (2013) 1.28
Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp Eye Res (2005) 1.26
Anti-inflammatory effects of FTY720 against viral-induced immunopathology: role of drug-induced conversion of T cells to become Foxp3+ regulators. J Immunol (2008) 1.26
Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis. J Virol (2007) 1.24
Qa-1b and CD94-NKG2a interaction regulate cytolytic activity of herpes simplex virus-specific memory CD8+ T cells in the latently infected trigeminal ganglia. J Immunol (2006) 1.19
Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus. Am J Pathol (2012) 1.19
IL-10 and natural regulatory T cells: two independent anti-inflammatory mechanisms in herpes simplex virus-induced ocular immunopathology. J Immunol (2008) 1.17
In vitro-generated antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells control the severity of herpes simplex virus-induced ocular immunoinflammatory lesions. J Virol (2008) 1.16
Treg control of antimicrobial T cell responses. Curr Opin Immunol (2006) 1.12
CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization. J Immunol (2004) 1.11
Herpetic eye disease: immunopathogenesis and therapeutic measures. Expert Rev Mol Med (2004) 1.07
Mechanisms of pathogenesis in herpetic immunoinflammatory ocular lesions. Vet Microbiol (2002) 1.07
T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses. Proc Natl Acad Sci U S A (2011) 1.07
Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor. J Immunol (2011) 1.07
In vivo kinetics of GITR and GITR ligand expression and their functional significance in regulating viral immunopathology. J Virol (2005) 1.06
Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes. J Virol (2002) 1.06
Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis. J Immunol (2004) 1.05
Pathogenesis of herpes stromal keratitis--a focus on corneal neovascularization. Prog Retin Eye Res (2012) 1.05
Controlling viral immuno-inflammatory lesions by modulating aryl hydrocarbon receptor signaling. PLoS Pathog (2011) 1.04
Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation. J Leukoc Biol (2006) 1.04
On the role of regulatory T cells during viral-induced inflammatory lesions. J Immunol (2012) 1.02
Immunization with chaperone-peptide complex induces low-avidity cytotoxic T lymphocytes providing transient protection against herpes simplex virus infection. J Virol (2002) 1.01
Galectin-1 reduces the severity of herpes simplex virus-induced ocular immunopathological lesions. J Immunol (2012) 1.00
Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. J Immunol (2011) 1.00
Protective and pathological roles of virus-specific and bystander CD8+ T cells in herpetic stromal keratitis. J Immunol (2004) 0.99
Molecular adjuvants for mucosal immunity. Immunol Rev (2004) 0.97
Cellular and population plasticity of helper CD4(+) T cell responses. Front Physiol (2013) 0.96
Enhanced viral immunoinflammatory lesions in mice lacking IL-23 responses. Microbes Infect (2007) 0.96
Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein. J Leukoc Biol (2004) 0.95
Emerged HA and NA mutants of the pandemic influenza H1N1 viruses with increasing epidemiological significance in Taipei and Kaohsiung, Taiwan, 2009-10. PLoS One (2012) 0.95
Mucosal application of plasmid-encoded IL-15 sustains a highly protective anti-Herpes simplex virus immunity. J Leukoc Biol (2005) 0.94
Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis. J Leukoc Biol (2004) 0.94
Herpetic stromal keratitis in the absence of viral antigen recognition. Cell Immunol (2002) 0.94
Role of inflammatory cytokine-induced cyclooxygenase 2 in the ocular immunopathologic disease herpetic stromal keratitis. J Virol (2005) 0.93
Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable. Br J Ophthalmol (2011) 0.93
Concomitant helper response rescues otherwise low avidity CD8+ memory CTLs to become efficient effectors in vivo. J Immunol (2004) 0.92
Codelivery of CCR7 ligands as molecular adjuvants enhances the protective immune response against herpes simplex virus type 1. J Virol (2003) 0.89
Critical role of microRNA-155 in herpes simplex encephalitis. J Immunol (2014) 0.89
An anti-inflammatory role of VEGFR2/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology. J Virol (2011) 0.88
Tregs and infections: on the potential value of modifying their function. J Leukoc Biol (2011) 0.88
Activation of endothelial roundabout receptor 4 reduces the severity of virus-induced keratitis. J Immunol (2011) 0.87
IL-12 suppresses the expression of ocular immunoinflammatory lesions by effects on angiogenesis. J Leukoc Biol (2002) 0.87
TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions. J Virol (2012) 0.87
In vivo rescue of defective memory CD8+ T cells by cognate helper T cells. J Leukoc Biol (2005) 0.86
Vascular endothelial growth factor receptor 2-based DNA immunization delays development of herpetic stromal keratitis by antiangiogenic effects. J Immunol (2006) 0.86
Neuroprotectin D1 reduces the severity of herpes simplex virus-induced corneal immunopathology. Invest Ophthalmol Vis Sci (2013) 0.86
Viruses and autoimmunity. Autoimmunity (2006) 0.85
Dendritic cells are required for optimal activation of natural killer functions following primary infection with herpes simplex virus type 1. J Virol (2009) 0.85
Heat-shock protein 70 acts as an effective adjuvant in neonatal mice and confers protection against challenge with herpes simplex virus. Vaccine (2005) 0.84
Natural killer cells as novel helpers in anti-herpes simplex virus immune response. J Virol (2008) 0.83
Pathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: implications for transplantation. J Exp Med (2010) 0.83
Rescue of memory CD8+ T cell reactivity in peptide/TLR9 ligand immunization by codelivery of cytokines or CD40 ligation. Virology (2005) 0.82
Macrophage IL-12p70 signaling prevents HSV-1-induced CNS autoimmunity triggered by autoaggressive CD4+ Tregs. Invest Ophthalmol Vis Sci (2011) 0.82
Influence of DNA encoding cytokines on systemic and mucosal immunity following genetic vaccination against herpes simplex virus. Microbes Infect (2003) 0.82
Blocking mouse MMP-9 production in tumor cells and mouse cornea by short hairpin (sh) RNA encoding plasmids. Oligonucleotides (2005) 0.82
Application of plasmid DNA encoding IL-18 diminishes development of herpetic stromal keratitis by antiangiogenic effects. J Immunol (2005) 0.82
Role of Stat4-mediated signal transduction events in the generation of aggressor CD4+ T cells in herpetic stromal keratitis pathogenesis. J Interferon Cytokine Res (2007) 0.82
A strategy for selective, CD4+ T cell-independent activation of virus-specific memory B cells for limiting dilution analysis. J Immunol Methods (2006) 0.81
Quantitative analysis of herpes simplex virus type 1-specific memory B cells generated by different routes of infection. Virology (2006) 0.80
IL-21 and IL-15 cytokine DNA augments HSV specific effector and memory CD8+ T cell response. Mol Immunol (2009) 0.80
Control of viral immunoinflammatory lesions by manipulating CD200:CD200 receptor interaction. Clin Immunol (2008) 0.79
Antigenic peptides complexed to phylogenically diverse Hsp70s induce differential immune responses. Cell Stress Chaperones (2003) 0.79
A novel flow cytometry based assay for quantification of corneal angiogenesis in the mouse model of herpetic stromal keratitis. Exp Eye Res (2005) 0.78
Homeostatic expansion of CD4(+) T cells upregulates VLA-4 and exacerbates HSV-induced corneal immunopathology. Microbes Infect (2008) 0.78
Viral immunology: challenges associated with the progression from bench to clinic. Trends Immunol (2002) 0.78